Data protection Impressum

Life sciences

Biopôle is joining forces with Swiss Healthcare Startups to extend the Vanguard accelerator to digital health start-ups in German-speaking Switzerland, while also welcoming Hôpital de La Tour to its Corporate Partnership Programme.

Biopôle expands its accelerator program and welcomes new corporate partner

5 August 2024

Asceneuron has secured USD 100 million in Series C funding to advance its mission of developing OGA inhibitors for neurodegenerative diseases like Alzheimer's.

Asceneuron raises USD 100 million to advance Alzheimer’s treatment

16 July 2024

Biopôle-based start-up Vanarix has secured CHF 4 million to initiate new clinical trials and automate the manufacturing of its Cartibeads.

Vanarix raises CHF 4 million to advance cartilage regeneration

15 July 2024

The canton of Neuchâtel is positioning itself as a future leader in medical diagnostic technologies with the creation of a new innovation cluster.

Neuchâtel embraces innovation in medical diagnostic technologies

8 July 2024

Revinax, founded in 2015 by neurosurgeon Maxime Ros in Montpellier, has decided to expand its activities by setting up at the Biopôle in Lausanne.

French company Revinax establishes operations at the Biopôle in Lausanne

3 July 2024

iOnctura has secured EUR 80 million in a Series B funding round to advance innovative cancer therapies, with a focus on neglected cancers such as uveal melanoma.

iOnctura secures EUR 80 million Series B financing to advance cancer treatments

25 June 2024

Thego.care has launched an online store for innovative medical armbands to enhance patient comfort and care.

Thego.care launches an online store for its innovative medical armbands

24 June 2024

SensArs, an EPFL spin-off specialized in neuromodulation technology for treating chronic pain and sensory loss, has secured a pre-seed investment from HTH and two grants worth EUR 1.1 million.

SensArs secures EUR 1.1 million to advance neuromodulation technology

17 June 2024

Aktiia has received CE mark approval for its non-cuff optical technology, enabling the start-up to access markets in over 40 countries.

Aktiia’s CE Mark approval opens doors to international expansion

17 June 2024

Dandelion Science and the Wyss Center Geneva have announced a partnership to develop a generative AI platform for non-invasive brain therapies.

Dandelion Science partners with Wyss Center to pioneer AI-based brain therapies

12 June 2024

1 … 8 9 10 11 12 13 14 15 16 … 44